X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Pfizer with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ADCOCK INGRAM (S. Africa) - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ADCOCK INGRAM
EQUITY SHARE DATA
    PFIZER
Mar-18
ADCOCK INGRAM
Jun-14
PFIZER/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,365357-   
Low Rs1,625258-   
Sales per share (Unadj.) Rs430.3106.3-  
Earnings per share (Unadj.) Rs78.7-26.8-  
Cash flow per share (Unadj.) Rs93.2-22.2-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.583.5-  
Shares outstanding (eoy) m45.75168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.62.9 160.2%   
Avg P/E ratio x25.3-11.5 -220.8%  
P/CF ratio (eoy) x21.4-13.9 -154.5%  
Price / Book Value ratio x3.43.7 92.3%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,27151,922 175.8%   
No. of employees `0002.64.3 61.3%   
Total wages/salary Rs m3,1433,259 96.4%   
Avg. sales/employee Rs Th7,484.84,180.1 179.1%   
Avg. wages/employee Rs Th1,195.0759.1 157.4%   
Avg. net profit/employee Rs Th1,369.1-1,053.3 -130.0%   
INCOME DATA
Net Sales Rs m19,68517,945 109.7%  
Other income Rs m1,143126 909.5%   
Total revenues Rs m20,82818,071 115.3%   
Gross profit Rs m5,003-3,110 -160.9%  
Depreciation Rs m663775 85.5%   
Interest Rs m4486 0.9%   
Profit before tax Rs m5,479-4,245 -129.1%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878265 708.2%   
Profit after tax Rs m3,601-4,522 -79.6%  
Gross profit margin %25.4-17.3 -146.7%  
Effective tax rate %34.3-6.2 -548.7%   
Net profit margin %18.3-25.2 -72.6%  
BALANCE SHEET DATA
Current assets Rs m24,16713,143 183.9%   
Current liabilities Rs m9,5447,395 129.1%   
Net working cap to sales %74.332.0 231.9%  
Current ratio x2.51.8 142.5%  
Inventory Days Days55111 49.7%  
Debtors Days Days29124 23.2%  
Net fixed assets Rs m9,5147,661 124.2%   
Share capital Rs m45883 549.1%   
"Free" reserves Rs m26,3750-   
Net worth Rs m26,83214,085 190.5%   
Long term debt Rs m254,950 0.5%   
Total assets Rs m36,90026,608 138.7%  
Interest coverage x1,305.5-7.7 -16,884.4%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.50.7 79.1%   
Return on assets %9.8-15.2 -64.4%  
Return on equity %13.4-32.1 -41.8%  
Return on capital %20.4-19.8 -103.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,4660-   
CASH FLOW
From Operations Rs m3,3181,532 216.6%  
From Investments Rs m-2,383-470 506.7%  
From Financial Activity Rs m-1,1044,492 -24.6%  
Net Cashflow Rs m-1695,554 -3.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.93 Rs / ZAR

Compare PFIZER With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PFIZER With: STRIDES PHARMA SCIENCE  JUBILANT LIFE SCIENCES  PROCTER & GAMBLE HEALTH  NATCO PHARMA  SUN PHARMA  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views On News

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today (Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jul 16, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS